1. Home
  2. ZVRA vs TMCI Comparison

ZVRA vs TMCI Comparison

Compare ZVRA & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • TMCI
  • Stock Information
  • Founded
  • ZVRA 2006
  • TMCI 2014
  • Country
  • ZVRA United States
  • TMCI United States
  • Employees
  • ZVRA N/A
  • TMCI N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ZVRA Health Care
  • TMCI Health Care
  • Exchange
  • ZVRA Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • ZVRA 400.8M
  • TMCI 371.1M
  • IPO Year
  • ZVRA 2015
  • TMCI 2021
  • Fundamental
  • Price
  • ZVRA $9.07
  • TMCI $5.53
  • Analyst Decision
  • ZVRA Strong Buy
  • TMCI Hold
  • Analyst Count
  • ZVRA 8
  • TMCI 6
  • Target Price
  • ZVRA $22.29
  • TMCI $9.18
  • AVG Volume (30 Days)
  • ZVRA 551.0K
  • TMCI 352.4K
  • Earning Date
  • ZVRA 08-12-2025
  • TMCI 08-05-2025
  • Dividend Yield
  • ZVRA N/A
  • TMCI N/A
  • EPS Growth
  • ZVRA N/A
  • TMCI N/A
  • EPS
  • ZVRA N/A
  • TMCI N/A
  • Revenue
  • ZVRA $40,588,000.00
  • TMCI $210,819,000.00
  • Revenue This Year
  • ZVRA $292.31
  • TMCI $10.61
  • Revenue Next Year
  • ZVRA $78.65
  • TMCI $10.36
  • P/E Ratio
  • ZVRA N/A
  • TMCI N/A
  • Revenue Growth
  • ZVRA 46.47
  • TMCI 7.54
  • 52 Week Low
  • ZVRA $4.20
  • TMCI $4.54
  • 52 Week High
  • ZVRA $9.76
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 58.37
  • TMCI 34.86
  • Support Level
  • ZVRA $8.71
  • TMCI $5.36
  • Resistance Level
  • ZVRA $9.37
  • TMCI $6.28
  • Average True Range (ATR)
  • ZVRA 0.33
  • TMCI 0.24
  • MACD
  • ZVRA -0.05
  • TMCI -0.00
  • Stochastic Oscillator
  • ZVRA 50.93
  • TMCI 16.30

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: